Description

[2-(3-Formyl-Benzoylamino)-Ethyl]-Carbamic Acid Benzyl Ester is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of complex active pharmaceutical ingredients (APIs). This compound matters for its role as a critical building block in medicinal chemistry, enabling the development of novel therapeutic agents. It is primarily needed by research institutions, pharmaceutical development companies, and fine chemical manufacturers focused on creating new drug candidates, particularly in areas requiring sophisticated molecular scaffolds.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of novel small-molecule drug candidates.
• Protease Inhibitor Research: Used in the development of compounds targeting specific enzyme pathways.
• Chemical Biology & Proteomics: Serves as a versatile scaffold for creating molecular probes and activity-based protein profiling (ABPP) reagents.
• Peptidomimetic Synthesis: Employed in the construction of peptide-like molecules with enhanced stability and bioavailability.
• Custom Synthesis & Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for client-specific API development projects.
• Academic & Industrial R&D: Utilized in exploratory research for discovering new pharmacophores and bioactive molecules.

Basic Information

Product Name	[2-(3-Formyl-Benzoylamino)-Ethyl]-Carbamic Acid Benzyl Ester
CAS No.	1820747-13-4
Molecular Formula	C18H18N2O4
Molecular Weight	326.35 g/mol
Synonyms	Benzyl N-[2-[[(3-formylphenyl)carbonyl]amino]ethyl]carbamate; Carbamic acid, N-[2-[[(3-formylbenzoyl)amino]ethyl]-, phenylmethyl ester; 3-Formyl-N-[2-[[(phenylmethoxy)carbonyl]amino]ethyl]benzamide; (3-Formylbenzoyl)-Gly-NH-Cbz; Cbz-Gly-3-formylbenzamide; N-Cbz-ethylenediamine-3-formylbenzamide
EINECS	Contact for details

Quality Control

Our [2-(3-Formyl-Benzoylamino)-Ethyl]-Carbamic Acid Benzyl Ester is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specifications and test results. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring reliability for your critical R&D and scale-up processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This material is easily oxidized and should be stored under an inert atmosphere (e.g., nitrogen or argon) for long-term preservation. Keep the container tightly sealed in a dry environment to minimize exposure to moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.